SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-055074
Filing Date
2023-05-02
Accepted
2023-05-02 17:01:51
Documents
14
Period of Report
2023-05-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2314366d1_8k.htm   iXBRL 8-K 30685
2 EXHIBIT 3.1 tm2314366d1_ex3-1.htm EX-3.1 111555
3 EXHIBIT 10.1 tm2314366d1_ex10-1.htm EX-10.1 142177
  Complete submission text file 0001104659-23-055074.txt   518813

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA imgn-20230501.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE imgn-20230501_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imgn-20230501_pre.xml EX-101.PRE 22597
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2314366d1_8k_htm.xml XML 3591
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 23880223
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences